Popular Plastics Industry International Weekly Newsletters

Tekni-Plexbusiness units will be exhibiting latest medical device compounds, medical tubing at Medtec China

The latest in medical tubing and compounds for medical device applications will be featured by Tekni-Plexbusiness. Natvar will be discussing its full line of precision-crafted medical tubing solutions including its newly-launched microextrusionalternative for neurovascular interventional therapies and surgical applications.

0 67,769

The latest in medical tubing and compounds for medical device applications will be featured by Tekni-Plexbusiness. Natvar will be discussing its full line of precision-crafted medical tubing solutions including its newly-launched microextrusionalternative for neurovascular interventional therapies and surgical applications. The new micro-tubing capability supports the growing need for highly-engineered materials,including tight tolerance microextrusions, for use in emerging procedures.

The company also is now making its silicone extrusion tubing available globally. Silicone extrusions are typically used for catheters, feeding tubes, drug delivery and peristaltic pump applications. Natvar’s latest investment in high-precision medical-grade silicone is the next step in providing a one-stop global solution for many complex medical applications.

Tekni-Plex’sColorite business unit is a leading producer of advanced medical-grade PVC compounds used by many of the world’s foremost healthcare and medical device manufacturers. At Medtec, it will be featuring its Cellene thermoplastic elastomer compounds which are suitable for a wide variety of medical devices, as well as packaging and other regulated markets. Cellene compounds are formulated to be silicone, latex, phthalate, halogen and PVC-free using FDA-compliant raw materials to meet USP Class VI and ISO 10993 standards.

Newsletter Subscription
Newsletter Subscription
Get the latest issue of Modern Plastics India Weekly Newsletter delivered directly into your inbox.
We have 100,000+ Newsletter Subscribers

Leave A Reply

Your email address will not be published.